1.Wrist Rehabilitation after Scapholunate Interosseous Ligament Reconstruction for a Collegiate Basketball Player
The Korean Journal of Sports Medicine 2019;37(3):101-106
For a basketball player who had scapholunate interosseous ligament injury related to sport, it is crucial to secure the active range of motion (ROM) and regain proprioception of the wrist. The player was involved in a 21-week rehabilitation procedure based on controlling pain with inactive treatments, restoring the wrist ROM with active treatments. We measured the visual analog scale (VAS) for pain, upper extremity functional outcome measurement (Disabilities of Arm, Shoulder, and Hand [DASH]) for the functionality, and active ROMs of the wrist. The VAS was decreased (after surgical treatment, 8.7; 1 week, 2.5; 12 week, 3–5; 21 week, 0). The DASH score was decreased when he returned to play (after surgical treatment, 78; end of the rehabilitation, 23). Wrist flexion and extension ROM were increased to 55° and 67°, respectively. To restore the function of the wrist for basketball performance, improvement of active ROM and proprioception is the primary goal to return to play.
Arm
;
Basketball
;
Hand
;
Ligaments
;
Proprioception
;
Range of Motion, Articular
;
Rehabilitation
;
Return to Sport
;
Shoulder
;
Sports
;
Upper Extremity
;
Visual Analog Scale
;
Wrist
2.Osteogenic Gene Expression on Anodizing Titanium Surface
Wonseok KIM ; Young Seok KIM ; Seongbae JEON ; Sangho JUN ; Euisuk LEE ; Hyonseok JANG ; Jongjin KWON ; Jaesuk RIM
Journal of the Korean Association of Maxillofacial Plastic and Reconstructive Surgeons 2012;34(2):91-99
Aggrecans
;
Alkaline Phosphatase
;
Bone Regeneration
;
Cell Culture Techniques
;
Collagen
;
Dental Implants
;
Durapatite
;
Electrons
;
Extracellular Matrix Proteins
;
Gene Expression
;
Integrin-Binding Sialoprotein
;
Mesenchymal Stromal Cells
;
Osteocalcin
;
Real-Time Polymerase Chain Reaction
;
Titanium
3.Psychiatric Comorbidity in Korean Children and Adolescents with Attention-Deficit Hyperactivity Disorder: Psychopathology According to Subtype.
Heejung BYUN ; Jaewon YANG ; Moonsoo LEE ; Wonseok JANG ; Jae Won YANG ; Ji Hae KIM ; Sungdo David HONG ; Yoo Sook JOUNG
Yonsei Medical Journal 2006;47(1):113-121
It is well-known that more than 50% of attention-deficit hyperactivity disorder (ADHD) cases also have comorbid psychiatric disorders. We evaluated the comorbid psychopathology of Korean children and adolescents with ADHD using a standardized diagnostic instrument. The Korean Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL-K) was administered and completed in 105 patients who had been referred to the outpatient and inpatient clinics at the Samsung Medical Center from March 2004 to May 2005. All of the cases were diagnosed as ADHD according to DSM-IV criteria. We analyzed their clinical characteristics and psychiatric comorbidities, and assessed the correlation of any comorbidity with gender, age and ADHD subtype. Among our 105 participants, 70 (66.7%) subjects were diagnosed with combined-type ADHD, 22 (21.0%) were the predominantly inattentive type, only 1 (1.0%) was determined to have the predominantly hyperactive-impulsive type of ADHD, and 12 (11.4%) were classified as not otherwise specified (NOS) ADHD. Eighty (76.2%) subjects had at least one comorbid disorder such as oppositional defiant disorder (n = 53, 50.5%), anxiety disorders (n = 35, 33.3%) and affective disorders (n = 15, 14.3%). Our patients ranged in age from five to 16 years. Among the factors including gender, age, and ADHD subtype, ADHD subtype was the only one significant to comorbidity in our study. The results of this study suggest that psychiatric comorbidity in Korean children with ADHD is similar to the results of previous studies in western countries. Out of all the ADHD subtypes, the combined-type group had a significantly higher ratio of comorbid disorders and psychopathologies.
Tic Disorders/epidemiology
;
Mood Disorders/epidemiology
;
Mental Disorders/*epidemiology
;
Male
;
Korea/epidemiology
;
Humans
;
Female
;
Elimination Disorders/epidemiology
;
Comorbidity
;
Child, Preschool
;
Child
;
Attention Deficit Disorder with Hyperactivity/classification/*epidemiology
;
Anxiety Disorders/epidemiology
;
Adolescent
4.Sex Difference in the Effect of Bifidobacterium longum on Repeated Water Avoidance Stress-induced Gut Dysbiosis in Wistar Rats
Soo In CHOI ; Nayoung KIM ; Ryoung Hee NAM ; Jae Young JANG ; Eun Hye KIM ; SungChan HA ; Kisung KANG ; Wonseok LEE ; Cheol Min SHIN ; Dong Ho LEE
Journal of Cancer Prevention 2024;29(1):16-23
Dysbiosis in gut microbiota is known to contribute to development of irritable bowel syndrome. We tried to investigate the effect of Bifidobacterium longum on repeated water avoidance stress (WAS) in a Wistar rat model. The three groups (no-stress, WAS, and WAS with B. longum) of rats were allocated to sham or WAS for 1 hour daily for 10 days, and B. longum was administered through gavage for 10 days. Fecal pellet numbers were counted at the end of each 1-hour session of WAS. After 10 days of repeated WAS, the rats were eutanized, and the feces were collected. WAS increased fecal pellet output (FPO) significantly in both sexes (P < 0.001), while the female B. longum group showed significantly decreased FPO (P = 0.005). However, there was no consistent change of myeloperoxidase activity and mRNA expression of interleukin-1ββ and TNF-αα. Mast cell infiltration at colonic submucosa increased in the female WAS group (P = 0.016). In terms of fecal microbiota, the repeated WAS groups in both sexes showed different beta-diversity compared to control and WAS with B. longum groups. WAS-induced mast cell infiltration was reduced by the administration of B. longum in female rats. Moreover, administration of B. longum relieved WAS-caused dysbiosis, especially in female rats. In conclusion, B. longum was beneficial for WAS-induced stress in rats, especially in females.
5.The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model
Soo In CHOI ; Nayoung KIM ; Ryoung Hee NAM ; Jae Young JANG ; Eun Hye KIM ; SungChan HA ; Kisung KANG ; Wonseok LEE ; HyeLim CHOI ; Yeon-Ran KIM ; Yeong-Jae SEOK ; Cheol Min SHIN ; Dong Ho LEE
Journal of Cancer Prevention 2023;28(4):219-219
6.Bortezomib Treatment for Refractory Antibody-Mediated Rejection Superimposed with BK Virus-Associated Nephropathy during the Progression of Recurrent C3 Glomerulonephritis.
Wonseok DO ; Jong Hak LEE ; Kyung Joo KIM ; Man Hoon HAN ; Hee Yeon JUNG ; Ji Young CHOI ; Sun Hee PARK ; Yong Lim KIM ; Chan Duck KIM ; Jang Hee CHO ; Youngae YANG ; Minjung KIM ; Inryang HWANG ; Kyu Yeun KIM ; Taehoon YIM ; Yong Jin KIM
The Journal of the Korean Society for Transplantation 2018;32(3):57-62
A 38-year-old man, who underwent a second kidney transplantation (KT), was admitted because of antibody-mediated rejection (AMR) complicated by BK virus-associated nephropathy (BKVAN). He was placed on hemodialysis at the age of 24 years because of membranoproliferative glomerulonephritis. At the age of 28 years, he underwent a living donor KT from his father; however, 1 year after the transplantation, he developed a recurrence of the primary glomerular disease, resulting in graft failure 2 years after the first KT. Ten years later, he received a deceased-donor kidney with a B-cell-positive-cross-match. He received 600 mg of rituximab before the KT with three cycles of plasmapheresis and immunoglobulin (0.5 g/kg) therapy after KT. During the follow-up, the first and second allograft biopsies at 4 and 10 months after KT revealed AMR with a recurrence of primary glomerular disease that was reclassified as C3 glomerulonephritis (C3GN). He received a steroid pulse, rituximab, plasmapheresis, and immunoglobulin therapies. The third allograft biopsy demonstrated that the BKVAN was complicated with AMR and C3GN. As the azotemia did not improve after repeated conventional therapies for AMR, one cycle of bortezomib (1.3 mg/m²×4 doses) was administered. The allograft function stabilized, and BK viremia became undetectable after 6 months. The present case suggests that bortezomib therapy may be applicable to patients with refractory AMR, even in cases complicated with BKVAN.
Adult
;
Allografts
;
Azotemia
;
Biopsy
;
BK Virus
;
Bortezomib*
;
Fathers
;
Follow-Up Studies
;
Glomerulonephritis*
;
Glomerulonephritis, Membranoproliferative
;
Graft Rejection
;
Humans
;
Immunization, Passive
;
Immunoglobulins
;
Kidney
;
Kidney Transplantation
;
Living Donors
;
Plasmapheresis
;
Recurrence
;
Renal Dialysis
;
Rituximab
;
Transplants
;
Viremia
7.The Protective Effect of Roseburia faecis Against Repeated Water Avoidance Stress-induced Irritable Bowel Syndrome in a Wister Rat Model
Soo In CHOI ; Nayoung KIM ; Ryoung Hee NAM ; Jae Young JANG ; Eun Hye KIM ; SungChan HA ; Kisung KANG ; Wonseok LEE ; HyeLim CHOI ; Yeon-Ran KIM ; Yeong-Jae SEOK ; Cheol Min SHIN ; Dong Ho LEE
Journal of Cancer Prevention 2023;28(3):93-105
Roseburia faecis, a butyrate-producing, gram-positive anaerobic bacterium, was evaluated for its usefulness against repeated water avoidance stress (WAS)-induced irritable bowel syndrome (IBS) in a rat model, and the underlying mechanism was explored.We divided the subjects into three groups: one without stress exposure, another subjected to daily 1-hour WAS for 10 days, and a third exposed to the same WAS regimen while also receiving two different R. faecis strains (BBH024 or R22-12-24) via oral gavage for the same 10-day duration. Fecal pellet output (FPO), a toluidine blue assay for mast cell infiltration, and fecal microbiota analyses were conducted using 16S rRNA metagenomic sequencing. Predictive functional profiling of microbial communities in metabolism was also conducted. FPO and colonic mucosal mast cell counts were significantly higher in the WAS group than in the control group (male, P = 0.004; female, P = 0.027). The administration of both BBH024 (male, P = 0.015; female, P = 0.022) and R22-12-24 (male, P = 0.003; female, P = 0.040) significantly reduced FPO. Submucosal mast cell infiltration in the colon showed a similar pattern in males. In case of fecal microbiota, the WAS with R. faecis group showed increased abundance of the Roseburia genus compared to WAS alone. Moreover, the expression of a gene encoding a D-methionine transport system substrate-binding protein was significantly elevated in the WAS with R. faecis group compared to that in the WAS (male, P = 0.028; female, P = 0.025) group. These results indicate that R. faecis is a useful probiotic for treating IBS and colonic microinflammation.
8.Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Jae Seung LEE ; Young Eun CHON ; Beom Kyung KIM ; Jun Yong PARK ; Do Young KIM ; Sang Hoon AHN ; Kwang-Hyub HAN ; Wonseok KANG ; Moon Seok CHOI ; Geum-Youn GWAK ; Yong-Han PAIK ; Joon Hyeok LEE ; Kwang Cheol KOH ; Seung Woon PAIK ; Hwi Young KIM ; Tae Hun KIM ; Kwon YOO ; Yeonjung HA ; Mi Na KIM ; Joo Ho LEE ; Seong Gyu HWANG ; Soon Sun KIM ; Hyo Jung CHO ; Jae Youn CHEONG ; Sung Won CHO ; Seung Ha PARK ; Nae-Yun HEO ; Young Mi HONG ; Ki Tae YOON ; Mong CHO ; Jung Gil PARK ; Min Kyu KANG ; Soo Young PARK ; Young Oh KWEON ; Won Young TAK ; Se Young JANG ; Dong Hyun SINN ; Seung Up KIM ;
Yonsei Medical Journal 2021;62(1):12-20
Purpose:
Alpha-fetoprotein (AFP) is a prognostic marker for hepatocellular carcinoma (HCC). We investigated the prognostic value of AFP levels in patients who achieved complete response (CR) to transarterial chemoembolization (TACE) for HCC.
Materials and Methods:
Between 2005 and 2018, 890 patients with HCC who achieved a CR to TACE were recruited. An AFP responder was defined as a patient who showed elevated levels of AFP (>10 ng/mL) during TACE, but showed normalization or a >50% reduction in AFP levels after achieving a CR.
Results:
Among the recruited patients, 569 (63.9%) with naïve HCC and 321 (36.1%) with recurrent HCC after complete resection were treated. Before TACE, 305 (34.3%) patients had multiple tumors, 219 (24.6%) had a maximal tumor size >3 cm, and 22 (2.5%) had portal vein tumor thrombosis. The median AFP level after achieving a CR was 6.36 ng/mL. After a CR, 473 (53.1%) patients experienced recurrence, and 417 (46.9%) died [median progression-free survival (PFS) and overall survival (OS) of 16.3 and 62.8 months, respectively]. High AFP levels at CR (>20 ng/mL) were independently associated with a shorter PFS [hazard ratio (HR)=1.403] and OS (HR=1.284), together with tumor multiplicity at TACE (HR=1.518 and 1.666, respectively). AFP non-responders at CR (76.2%, n=359 of 471) showed a shorter PFS (median 10.5 months vs. 15.5 months, HR=1.375) and OS (median 41.4 months vs. 61.8 months, HR=1.424) than AFP responders (all p=0.001).
Conclusion
High AFP levels and AFP non-responders were independently associated with poor outcomes after TACE. AFP holds clinical implications for detailed risk stratification upon achieving a CR after TACE.